ambroxol has been researched along with Pain in 5 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5, 5, and 10 mg ambroxol (AXS) per application (4 actuations/application) in relieving acute sore throat vs." | 9.20 | Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat. ( de Mey, C; Koelsch, S; Lakha, DR; Patel, J; Richter, E, 2015) |
| "Ambroxol has a local anaesthetic action and is marketed for pain relief for sore throat." | 8.90 | Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis. ( Chenot, JF; Friede, T; Weber, P, 2014) |
| "8 contributes to capsaicin-induced and peripheral ischemia-induced MA and TH." | 7.78 | The differential effect of intrathecal Nav1.8 blockers on the induction and maintenance of capsaicin- and peripheral ischemia-induced mechanical allodynia and thermal hyperalgesia. ( Beitz, AJ; Kang, SY; Lee, JH; Moon, JY; Park, JH; Roh, DH; Song, S; Yoon, SY, 2012) |
| "Ambroxol's effects were compared with those of gabapentin." | 5.33 | Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. ( Arndt, K; Gaida, W; Klinder, K; Weiser, T, 2005) |
| "5, 5, and 10 mg ambroxol (AXS) per application (4 actuations/application) in relieving acute sore throat vs." | 5.20 | Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat. ( de Mey, C; Koelsch, S; Lakha, DR; Patel, J; Richter, E, 2015) |
| "Ambroxol has a local anaesthetic action and is marketed for pain relief for sore throat." | 4.90 | Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis. ( Chenot, JF; Friede, T; Weber, P, 2014) |
| "8 contributes to capsaicin-induced and peripheral ischemia-induced MA and TH." | 3.78 | The differential effect of intrathecal Nav1.8 blockers on the induction and maintenance of capsaicin- and peripheral ischemia-induced mechanical allodynia and thermal hyperalgesia. ( Beitz, AJ; Kang, SY; Lee, JH; Moon, JY; Park, JH; Roh, DH; Song, S; Yoon, SY, 2012) |
| "Ambroxol's effects were compared with those of gabapentin." | 1.33 | Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. ( Arndt, K; Gaida, W; Klinder, K; Weiser, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chenot, JF | 1 |
| Weber, P | 1 |
| Friede, T | 1 |
| de Mey, C | 1 |
| Patel, J | 1 |
| Lakha, DR | 1 |
| Richter, E | 1 |
| Koelsch, S | 1 |
| Moon, JY | 1 |
| Song, S | 1 |
| Yoon, SY | 1 |
| Roh, DH | 1 |
| Kang, SY | 1 |
| Park, JH | 1 |
| Beitz, AJ | 1 |
| Lee, JH | 1 |
| Gaida, W | 1 |
| Klinder, K | 1 |
| Arndt, K | 1 |
| Weiser, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Ambroxol on the Inflammatory Markers and Clinical Outcome of Patients With Diabetic Peripheral Neuropathy[NCT05558878] | 80 participants (Anticipated) | Interventional | 2022-10-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ambroxol and Pain
| Article | Year |
|---|---|
Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis.
Topics: Ambroxol; Dosage Forms; Humans; Pain; Pharyngitis | 2014 |
1 trial available for ambroxol and Pain
| Article | Year |
|---|---|
Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat.
Topics: Acute Disease; Adult; Ambroxol; Dose-Response Relationship, Drug; Double-Blind Method; Expectorants; | 2015 |
3 other studies available for ambroxol and Pain
| Article | Year |
|---|---|
Ambroxol lozenges: new drug. Sore throat: better to just suck on hard candy.
Topics: Adolescent; Adult; Ambroxol; Anesthetics; Drug Approval; France; Humans; Pain; Pharyngitis | 2009 |
The differential effect of intrathecal Nav1.8 blockers on the induction and maintenance of capsaicin- and peripheral ischemia-induced mechanical allodynia and thermal hyperalgesia.
Topics: Ambroxol; Aniline Compounds; Animals; Capsaicin; Disease Models, Animal; Dose-Response Relationship, | 2012 |
Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain.
Topics: Ambroxol; Amines; Analgesics; Animals; Behavior, Animal; Constriction, Pathologic; Cyclohexanecarbox | 2005 |